
Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

I'm PortAI, I can summarize articles.
Inovio Pharmaceuticals Inc. stock rose 1.78% to $2.29, outperforming competitors in a weak market session. The NASDAQ fell 0.09% and Dow Jones fell 0.04%. Inovio's stock is 23.13% below its 52-week high. Competitors like Johnson & Johnson fell 0.07%, Statera Biopharma fell 66.67%, and Pfizer rose 0.24%. Trading volume was below average.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

